DBS Target Selection for Meige Syndrome

Researchers recently conducted a significant trial comparing different targets for Meige syndrome DBS. This randomized, controlled, double-blind multicenter study evaluated the safety and efficacy of the globus pallidus internus (GPi) and the subthalamic nucleus (STN). Consequently, clinicians now have high-quality evidence to guide surgical decisions for this challenging movement disorder. Both targets demonstrated comparable improvements in motor symptoms and patient quality of life.

Optimal Targets for Meige syndrome DBS

The 62 participants received either GPi or STN stimulation. After a 12-month follow-up, both groups achieved nearly 60% improvement in motor function scores. Furthermore, mood and cognitive stability remained consistent across both cohorts. However, the STN-DBS group required significantly less total electrical energy than the GPi group. Notably, researchers used lead-mapping technology to identify precise stimulation "sweet spots." For GPi-DBS, the posterolateral dorsal pallidum offered the best outcomes. In contrast, the dorsal STN proved to be the ideal site for the subthalamic target.

Predictors of Meige syndrome DBS Success

Identifying which patients respond best to therapy is vital for clinical success. The study found that preoperative impairment in speech and swallowing negatively impacts efficacy. Specifically, patients with higher disability scores in these areas experienced less overall benefit from surgery. Therefore, clinicians should carefully screen these subscores during preoperative assessments. This trial provides a refined roadmap for functional neurosurgeons treating refractory cases of Meige syndrome.

FAQ: Which brain target is better for Meige syndrome?

Both the GPi and STN targets provide similar motor improvements and safety profiles. However, STN-DBS typically requires lower electrical energy settings to achieve these results.

FAQ: How does Meige syndrome DBS affect quality of life?

The trial showed that Meige syndrome DBS significantly enhances quality of life, mood, and motor control, with results remaining stable for at least one year post-surgery.

Disclaimer: This content is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.

References

Wu Y et al. Pallidus internus versus subthalamic nucleus deep brain stimulation for Meige syndrome: a randomized, controlled, double-blind multicenter trial. J Neurosurg. 2026 Feb 20. doi: 10.3171/2025.9.JNS251188. PMID: 41719550.

Guizhi Wu et al. Globus pallidus internus versus subthalamic nucleus deep brain stimulation for Meige syndrome: a retrospective study on short- and long-term efficacy. J Neurosurg. 2026 Feb 6. doi: 10.3171/2025.9.JNS251420. PMID: 41650451.